MIST vs RVTY · rev $797.0K vs P/E 42, rev $1.44B
Milestone Pharmaceuticals Inc (MIST) versus Revvity Inc. (RVTY) — a side-by-side from cached financials, not a winner call.
Milestone Pharmaceuticals Inc (MIST) is a biotechnology company listed on US.
Revvity Inc. (RVTY) is a diagnostics & research company listed on US.
Latest reported MIST revenue for 2026-06-30 was $797.0K. Net income was -$54.7M. MIST currently screens at market cap $160.6M.
Latest reported RVTY revenue for 2026-07-05 was $1.44B. Net income was $92.5M. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
MIST currently screens at market cap $160.6M. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
Not investment advice. Open the MIST and RVTY stock pages for the full models.
Not investment advice.